The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma-Reference-Cited by-同舟云学术

The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

Published:2011-04-23 Issue:8 Volume:56 Page:2491-2496
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Singh Sundeep,Tang Shou-jiang,Sreenarasimhaiah Jayaprakash,Lara Luis F.,Siddiqui Ali

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-011-1709-8.pdf

Reference11 articles.

1. Koprowski H, Steplewski Z, Mitchell K, et al. Colorectal carcinoma antigen detected by hybridoma antibodies. Somatic Cell Genet. 1979;5:957–972.

2. Itkowitz SH, Kim YS. New carbohydrate tumor markers. Gastroenterology. 1986;90:491–494.

3. Tempero MA, Uchida E, Takasaki H, et al. Relationship of carbohydrate antigen and Lewis antigens in pancreatic cancer. Cancer Res. 1987;47:5501–5503.

4. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33:266–270.

5. Steinberg W. The clinical utility of the CA19-9 tumor-associated antigen. Am J Gastroenterol. 1990;85:350–355.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma;International Journal of Biological Macromolecules;2024-09

2. A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes;eLife;2024-03-26

3. A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes;2024-03-04

4. Multifunctional exosome-driven pancreatic cancer diagnostics and therapeutics;Extracellular Vesicle;2023-12

5. A novel machine learning algorithm picks proteome signature to specifically identify cancer exosomes;ELIFE;2023-10-03